表紙
市場調查報告書

口服式生技藥品、生物相似藥的全球市場分析 (2020∼30年)

Oral Biologics & Biosimilars Market Global Report 2020-30

出版商 The Business Research Company 商品編碼 931980
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
口服式生技藥品、生物相似藥的全球市場分析 (2020∼30年) Oral Biologics & Biosimilars Market Global Report 2020-30
出版日期: 2020年04月10日內容資訊: 英文
簡介

本報告提供全球口服式的生技藥品及生物相似藥的市場結構、趨勢相關分析,市場的主要特徵、結構,及整體市場規模、成長率趨勢預測 (2015∼2019年,2023年,2025年,2030年),各治療藥物、各疾病、各地區、主要國家詳細趨勢,跟主要的宏觀經濟指標的對比,主要企業的簡介,近幾年的主要趨勢等調查。

第1章 摘要整理

第2章 口服式生技藥品、生物相似藥市場特徵

第3章 口服式生技藥品、生物相似藥市場:市場規模、成長率

  • 市場規模:成果值 (以金額為準,2015∼2019年)
  • 市場規模:預測值 (以金額為準,2019∼2023年,2025年,2030年)
    • 推動市場要素
    • 阻礙市場要素

第4章 口服式生技藥品、生物相似藥市場:各領域分析

  • 各治療藥物的市場規模 (以金額為準,成果值、預測值)
    • 淋巴球調製器
    • 白細胞介素抑制劑
    • 腫瘤壞死因子 (TNF) Alpha抑制劑
  • 各疾病的市場規模 (以金額為準,成果值、預測值)
    • 氣喘
    • 克隆氏症
    • 癌症
    • 關節炎
    • 糖尿病
    • 多發性骨髓瘤
    • 腸炎
    • 多發性硬化症
    • 肉瘤
    • 乾癬,其他

第5章 口服式生技藥品、生物相似藥市場:各地區、各國分析

  • 各地區的市場規模 (以金額為準,成果值、預測值)
  • 各國市場規模 (以金額為準,成果值、預測值)

第6章 亞太地區的口服式生技藥品、生物相似藥市場

  • 市場概要
  • 各治療藥物的市場規模 (以金額為準,成果值、預測值)

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐的口服式生技藥品、生物相似藥市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐的口服式生技藥品、生物相似藥市場

第18章 俄羅斯市場

第19章 北美的口服式生技藥品、生物相似藥市場

第20章 美國市場

第21章 南美的口服式生技藥品、生物相似藥市場

第22章 巴西市場

第23章 中東的口服式生技藥品、生物相似藥市場

第24章 非洲的口服式生技藥品、生物相似藥市場

第25章 口服式生技藥品、生物相似藥市場:競爭環境和企業簡介

  • 競爭環境
  • 企業簡介
    • Novartis
    • Rani Therapeutics
    • Eli Lilly and Co.
    • AstraZeneca plc
    • Novo Nordisk A/S

第26章 口服式生技藥品、生物相似藥市場上主要企業合併、收購 (M&A)

第27章 口服式生技藥品、生物相似藥市場趨勢與策略

第28章 口服式生技藥品、生物相似藥市場:未來展望與潛在力分析

第29章 附錄

目錄

‘Oral Biologics & Biosimilars Market Market Global Report 2020-30 ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics & biosimilars market market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oral biologics & biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Oral Biologics & Biosimilars Market market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oral biologics & biosimilars market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The oral biologics & biosimilars market market section of the report gives context. It compares the oral biologics & biosimilars market market with other segments of the oral biologics & biosimilars market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oral biologics & biosimilars market indicators comparison.

Scope:

  • Markets Covered: 1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors
  • 2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
  • Companies Mentioned: Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S
  • Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oral Biologics & Biosimilars Market Market Characteristics

3. Oral Biologics & Biosimilars Market Market Size And Growth

  • 3.1. Global Oral Biologics & Biosimilars Market Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Oral Biologics & Biosimilars Market Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Oral Biologics & Biosimilars Market Market Segmentation

  • 4.1. Global Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Lymphocyte Modulators
    • Interleukin Inhibitors
    • Tumor Necrosis Factor-Alpha Inhibitors
  • 4.2. Global Oral Biologics & Biosimilars Market Market, Segmentation By Disease, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Asthma
    • Crohn'S Disease
    • Carcinoma
    • Arthritis
    • Diabetes
    • Multiple Myeloma
    • Enterocolitis
    • Multiple Sclerosis
    • Sarcoma
    • Psoriasis and Others

5. Oral Biologics & Biosimilars Market Market Regional And Country Analysis

  • 5.1. Global Oral Biologics & Biosimilars Market Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Oral Biologics & Biosimilars Market Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Oral Biologics & Biosimilars Market Market

  • 6.1. Asia-Pacific Oral Biologics & Biosimilars Market Market Overview
  • 6.2. Asia-Pacific Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Oral Biologics & Biosimilars Market Market

  • 7.1. China Oral Biologics & Biosimilars Market Market Overview
  • 7.2. China Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Oral Biologics & Biosimilars Market Market

  • 8.1. India Oral Biologics & Biosimilars Market Market Overview
  • 8.2. India Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Oral Biologics & Biosimilars Market Market

  • 9.1. Japan Oral Biologics & Biosimilars Market Market Overview
  • 9.2. Japan Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Oral Biologics & Biosimilars Market Market

  • 10.1. Australia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Oral Biologics & Biosimilars Market Market

  • 11.1. Indonesia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Oral Biologics & Biosimilars Market Market

  • 12.1. South Korea Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Oral Biologics & Biosimilars Market Market

  • 13.1. Western Europe Oral Biologics & Biosimilars Market Market Overview
  • 13.2. Western Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Oral Biologics & Biosimilars Market Market

  • 14.1. UK Oral Biologics & Biosimilars Market Market Overview
  • 14.2. UK Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Oral Biologics & Biosimilars Market Market

  • 15.1. Germany Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Oral Biologics & Biosimilars Market Market

  • 16.3. France Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Oral Biologics & Biosimilars Market Market

  • 17.1. Eastern Europe Oral Biologics & Biosimilars Market Market Overview
  • 17.2. Eastern Europe Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Oral Biologics & Biosimilars Market Market

  • 18.1. Russia Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Oral Biologics & Biosimilars Market Market

  • 19.1. North America Oral Biologics & Biosimilars Market Market Overview
  • 19.2. North America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Oral Biologics & Biosimilars Market Market

  • 20.1. USA Oral Biologics & Biosimilars Market Market Overview
  • 20.2. USA Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Oral Biologics & Biosimilars Market Market

  • 21.1. South America Oral Biologics & Biosimilars Market Market Overview
  • 21.2. South America Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Oral Biologics & Biosimilars Market Market

  • 22.1. Brazil Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Oral Biologics & Biosimilars Market Market

  • 23.1. Middle East Oral Biologics & Biosimilars Market Market Overview
  • 23.2. Middle East Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Oral Biologics & Biosimilars Market Market

  • 24.1. Africa Oral Biologics & Biosimilars Market Market Overview
  • 24.2. Africa Oral Biologics & Biosimilars Market Market, Segmentation By Therapy, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Oral Biologics & Biosimilars Market Market Competitive Landscape And Company Profiles

  • 25.1. Oral Biologics & Biosimilars Market Market Competitive Landscape
  • 25.2. Oral Biologics & Biosimilars Market Market Company Profiles
    • 25.2.1. Novartis
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Rani Therapeutics
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Eli Lilly and Co.
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. AstraZeneca plc
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Novo Nordisk A/S
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market Market

27. Oral Biologics & Biosimilars Market Market Trends And Strategies

28. Oral Biologics & Biosimilars Market Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer